Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)th

Details Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)th Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)th

1988-04-06

1989-09-12

Gerstl, Robert

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A51K 31425

Patent

active

048660825

ABSTRACT:
A method for modifying the balance between bone production and bone resorption in a host animal by administration of (-)-N-[[(5-chloro-benzothiazolyl)-thio]phenylacetyl]-L-cysteine to inhibit bone loss.

REFERENCES:
patent: 4367233 (1983-01-01), Clark
patent: 4391824 (1983-07-01), Siuta
patent: 4567267 (1986-01-01), Wel
patent: 4599361 (1986-07-01), Dickens
patent: 4609667 (1986-09-01), Clark
Delaisse, Bone, 8, 305 (1987).

Affiliated with

Also associated with

Rating

Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)th does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)th will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-916570